brain wave

A nerve cell affected by Alzheimer's disease
Cognito Therapeutics touts positive Phase 2 results for device-delivered Alzheimer's treatment
By Dave Muoio | 03:25 pm | March 10, 2021
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.